229 related articles for article (PubMed ID: 20152220)
1. Does aspirin use adversely influence intermediate-term postdischarge outcomes for hospitalized patients who are treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers? Findings from Organized Program to Facilitate Life-Saving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
Levy PD; Nandyal D; Welch RD; Sun JL; Pieper K; Ghali JK; Fonarow GC; Gheorghiade M; O'Connor CM
Am Heart J; 2010 Feb; 159(2):222-230.e2. PubMed ID: 20152220
[TBL] [Abstract][Full Text] [Related]
2. Long-term trends of angiotensin-converting enzyme inhibitor and angiotensin-receptor blocker use after heart failure hospitalization in community-dwelling seniors.
Setoguchi S; Levin R; Winkelmayer WC
Int J Cardiol; 2008 Apr; 125(2):172-7. PubMed ID: 17997175
[TBL] [Abstract][Full Text] [Related]
3. Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failure.
Tsuchihashi-Makaya M; Furumoto T; Kinugawa S; Hamaguchi S; Goto K; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
Hypertens Res; 2010 Mar; 33(3):197-202. PubMed ID: 19960016
[TBL] [Abstract][Full Text] [Related]
4. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
O'Connor CM; Abraham WT; Albert NM; Clare R; Gattis Stough W; Gheorghiade M; Greenberg BH; Yancy CW; Young JB; Fonarow GC
Am Heart J; 2008 Oct; 156(4):662-73. PubMed ID: 18926148
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF.
Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
J Card Fail; 2007 Nov; 13(9):722-31. PubMed ID: 17996820
[TBL] [Abstract][Full Text] [Related]
6. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker adherence in patients with primary versus secondary diagnosis of heart failure.
Brackbill ML; Bashaw-Keaton R; Sytsma CS
Am J Manag Care; 2007 Oct; 13(10):568-70. PubMed ID: 17927461
[TBL] [Abstract][Full Text] [Related]
9. Effects of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy after hospital discharge on subsequent rehospitalization for acute myocardial infarction and heart failure.
Hess G; Preblick R; Hill J; Plauschinat CA; Yaskin J
Congest Heart Fail; 2009; 15(4):170-5. PubMed ID: 19627290
[TBL] [Abstract][Full Text] [Related]
10. Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF).
Fonarow GC; Abraham WT; Albert NM; Gattis Stough W; Gheorghiade M; Greenberg BH; O'Connor CM; Pieper K; Sun JL; Yancy CW; Young JB;
Arch Intern Med; 2007 Jul; 167(14):1493-502. PubMed ID: 17646603
[TBL] [Abstract][Full Text] [Related]
11. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry.
Fonarow GC; Stough WG; Abraham WT; Albert NM; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
J Am Coll Cardiol; 2007 Aug; 50(8):768-77. PubMed ID: 17707182
[TBL] [Abstract][Full Text] [Related]
12. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
13. Heart failure: is there a role for angiotensin II receptor blockers?
Boucher M; Ma J
Issues Emerg Health Technol; 2002 Sep; (38):1-4. PubMed ID: 12243202
[TBL] [Abstract][Full Text] [Related]
14. Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure.
McAlister FA; Ghali WA; Gong Y; Fang J; Armstrong PW; Tu JV
Circulation; 2006 Jun; 113(22):2572-8. PubMed ID: 16735672
[TBL] [Abstract][Full Text] [Related]
15. Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge.
Butler J; Arbogast PG; Daugherty J; Jain MK; Ray WA; Griffin MR
J Am Coll Cardiol; 2004 Jun; 43(11):2036-43. PubMed ID: 15172409
[TBL] [Abstract][Full Text] [Related]
16. Aspirin-angiotensin-converting enzyme inhibitor coadministration and mortality in patients with heart failure: a dose-related adverse effect of aspirin.
Guazzi M; Brambilla R; Reina G; Tumminello G; Guazzi MD
Arch Intern Med; 2003 Jul; 163(13):1574-9. PubMed ID: 12860580
[TBL] [Abstract][Full Text] [Related]
17. Underutilization of angiotensin converting enzyme inhibitors among heart failure patients.
Lean QY; Shamsuddin N; Wan Ahmad WA
Med J Malaysia; 2008 Aug; 63(3):216-21. PubMed ID: 19248693
[TBL] [Abstract][Full Text] [Related]
18. Changes in adherence to evidence-based medications in the first year after initial hospitalization for heart failure: observational cohort study from 1994 to 2003.
Lamb DA; Eurich DT; McAlister FA; Tsuyuki RT; Semchuk WM; Wilson TW; Blackburn DF
Circ Cardiovasc Qual Outcomes; 2009 May; 2(3):228-35. PubMed ID: 20031842
[TBL] [Abstract][Full Text] [Related]
19. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.
Fonarow GC; Abraham WT; Albert NM; Gattis WA; Gheorghiade M; Greenberg B; O'Connor CM; Yancy CW; Young J
Am Heart J; 2004 Jul; 148(1):43-51. PubMed ID: 15215791
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
Heinze G; Mitterbauer C; Regele H; Kramar R; Winkelmayer WC; Curhan GC; Oberbauer R
J Am Soc Nephrol; 2006 Mar; 17(3):889-99. PubMed ID: 16481415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]